Price movement over the last 24 hours
Bio Protocol vs MyShell — how do they compare? Bio Protocol trades at Rp521.85 (market cap Rp1,17T, Rp248,44M 24h volume), while MyShell trades at Rp359.96 (market cap Rp150,86M, Rp73,25M 24h volume). The key difference: Bio Protocol is far larger — about 7755.5× MyShell's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 409,1M / 1B SHELL (41%) for MyShell. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and MyShell for 20 Days on average.
| BIO | SHELL | |
|---|---|---|
Market Cap | Rp1,17T | Rp150,86M |
Volume (24h) | Rp248,44M | Rp73,25M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 409,1M / 1B SHELL (41%) |
Typical Hold Time | 16 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
MyShell (SHELL) is trading at Rp382.46, showing a bearish technical signal with moving averages indicating strong selling pressure, though oscillators are neutral. The token is near its S1 support level of Rp382, with a market cap of Rp150.13 million and a circulating supply of 392.9 thousand SHELL out of a maximum 1 million. No recent protocol updates or ecosystem news are available, limiting fundamental catalysts.
Overall outlook is cautious due to bearish momentum and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve high volatility, limited exchange depth, and regulatory uncertainties in the crypto space. Investors should monitor support breaks and trading volume changes closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →MyShell is a user-friendly platform where anyone can create, share, and own AI agents. It connects AI and blockchain using agent frameworks, open-source models, and a creative AI community. The platform also delivers AI-driven tools and entertainment, giving users a sense of shared ownership.
Read more on SHELL →